Suraksha Diagnostic IPO is a book-built issue with a total size of ₹846.25 crore. The offering comprises an entire offer for sale of 1.92 crore equity shares.
The subscription period for the Suraksha Diagnostic IPO opens on November 29, 2024, and closes on December 3, 2024. The allotment is expected to be finalized on Wednesday, December 4, 2024. The shares are slated to list on the BSE and NSE, with the tentative listing date set for Friday, December 6, 2024.
Suraksha Diagnostic Limited operates in the healthcare sector. They provide a comprehensive range of diagnostic services, including pathology and radiology testing, as well as medical consultation services. Their services cover routine tests, advanced diagnostics, and specialized medical consultations.
The IPO price band is set between ₹420 and ₹441 per share. Retail investors must apply for a minimum lot size of 34 shares, requiring an investment of ₹14,994 at the upper price band. Small Non-Institutional Investors (sNII) must apply for a minimum of 14 lots, or 476 shares, amounting to ₹209,916. Big Non-Institutional Investors (bNII) must apply for 67 lots, or 2,278 shares, translating to ₹1,004,598.
ICICI Securities Limited, Nuvama Wealth Management Limited, and SBI Capital Markets Limited are the book-running lead managers for this IPO, with Kfin Technologies Limited acting as the registrar.
Suraksha Diagnostic IPO Details:
| Company Name | Suraksha Diagnostic Limited |
| Sector | Healthcare |
| IPO Type | Mainboard |
| IPO Open date | 29th Nov 2024 |
| IPO Close date | 03rd Dec 2024 |
| OFS | |
| Listing Exchanges | NSE, BSE |
| Share Holding Pre-issue | |
| DRHP Draft Prospectus | Click to check |
| RHP Draft Prospects | Click to check |
Suraksha Diagnostic IPO Lot Size:
| Application | Lot Size | Shares | Amount |
| Retail (Min) | 1 | 34 | 14,994 |
| sHNI (Min) | 14 | 476 | 2,09,916 |
| bHNI (Min) | 67 | 2278 | 10,04,598 |
Suraksha Diagnostic IPO Timeline:
| IPO Open Date | 29th Nov 2024 |
| IPO Close Date | 03rd Dec 2024 |
| Basis of Allotment | 04th Dec 2024 |
| Refund Initiation Date | 05th Dec 2024 |
| Shares Credit to Demat | 05th Dec 2024 |
| Listing Date | 06th Dec 2024 |
Things to Consider before applying for an IPO
Financial Performance: Review Suraksha Diagnostic’s Financials to understand its revenue, profitability, and growth prospects.
Industry Outlook: Consider the overall health of India’s Healthcare Industry.
Valuation: Compare the price band to similar companies in the industry to see if the IPO is priced fairly.
Management Team: Research the experience and capabilities of the management team.
Our Verdict
This IPO offers a good opportunity to invest in Suraksha Diagnostic and be a part of its growth.
FAQ
What is Grey Market Premium (GMP)?
The Grey Market Premium (GMP) represents the price at which an Initial Public Offering (IPO) is traded in the unregulated grey market before its official listing. It serves as an indicator of how the IPO might perform on the listing day. Seeing the latest GMP, investors can estimate the listing performance of the IPO.
